11 studies found for:    11784875 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
Intervention: Drug: BAY 43-9006 (Sorafenib)
2 Unknown  Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: sunitinib, docetaxel, cisplatin
3 Completed
Has Results
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: FDG-PET;   Drug: Pemetrexed;   Drug: Sirolimus;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic acid tablets;   Drug: Dexamethasone tablets
4 Active, not recruiting Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small-Cell Lung
Intervention:
5 Not yet recruiting A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Carcinoma of the Lung.
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin
6 Unknown  Tarceva Italian Lung Optimization tRial
Condition: Non Small Cell Lung Cancer (NSCLC)
Interventions: Drug: Erlotinib;   Drug: Docetaxel
7 Recruiting Biomarker Discovery and Validation in Lung Cancer
Condition: Lung Cancer
Intervention: Procedure: Collection of biospecimen
8 Completed
Has Results
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
Conditions: NSCLC;   Solid Tumors
Interventions: Drug: YM155;   Drug: Carboplatin;   Drug: Paclitaxel
9 Recruiting Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Lenalidomide
10 Unknown  Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: erlotinib;   Procedure: FDG-/FLT-PET
11 Recruiting Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy
Condition: Squamous Cell Lung Cancer
Interventions: Drug: Boanmycin;   Drug: Docetaxel

Indicates status has not been verified in more than two years